Champions Oncology (CSBR) Shares Outstanding (Diluted Average) (2013 - 2026)

Champions Oncology's Shares Outstanding (Diluted Average) history runs 14 years deep, the most recent figure standing at $13.8 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Diluted Average) fell 3.89% year-over-year to $13.8 million; the TTM figure through Jan 2026 stood at $13.8 million (down 3.89% YoY), while the FY2025 annual figure was $14.3 million, up 5.31% from the prior year.
• Shares Outstanding (Diluted Average) was $13.8 million for Q1 2026 at Champions Oncology, roughly flat from $13.8 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $14.4 million in Q1 2022 to a low of $13.5 million in Q3 2023.
• Historically, Shares Outstanding (Diluted Average) has averaged $13.8 million across 5 years, with a median of $13.8 million in 2025.
• The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Diluted Average) decreased 5.76% in 2023, then grew 5.67% in 2025.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $13.5 million in 2022, then gained by 0.01% to $13.5 million in 2023, then climbed by 3.7% to $14.0 million in 2024, then declined by 1.93% to $13.8 million in 2025, then rose by 0.34% to $13.8 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $13.8 million (Q1 2026), $13.8 million (Q4 2025), and $13.8 million (Q3 2025), per Business Quant data.